Vascular functions of the plasminogen activation system.
about
Regulation of plasminogen activator inhibitor-1 expression in endothelial cells with exposure to metal nanoparticlesFunctional Regulation of the Plasma Protein Histidine-Rich Glycoprotein by Zn2+ in Settings of Tissue InjuryPlasmin promotes foam cell formation by increasing macrophage catabolism of aggregated low-density lipoprotein.Distinct clinical and immunologic profiles in severe malarial anemia and cerebral malaria in ZambiaExtracellular matrix biomarker, fibulin-1, is closely related to NT-proBNP and soluble urokinase plasminogen activator receptor in patients with aortic valve stenosis (the SEAS study).Circulating levels of inflammatory markers in intrauterine growth restriction.Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditionsRegulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator.The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis.Chemical Antagonists of Plasminogen Activator Inhibitor-1: Mechanisms of Action and Therapeutic Potential in Vascular Disease.Fibrinogen counteracts the antiadhesive effect of fibrin-bound plasminogen by preventing its activation by adherent U937 monocytic cellsPlasminogen mediates the atherogenic effects of macrophage-expressed urokinase and accelerates atherosclerosis in apoE-knockout micePlasminogen activator inhibitor-1 and thrombotic cerebrovascular diseasesMultimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart StudyThe changes in the endothelial function and haemostatic and inflammatory parameters in subclinical and overt hyperthyroidism.Evaluation of coagulation activation after rhinovirus infection in patients with asthma and healthy control subjects: an observational study.Expression of uPA, tPA, and PAI-1 in Calcified Aortic Valves.Programmed cell removal: a new obstacle in the road to developing cancer.The biochemistry and regulation of S100A10: a multifunctional plasminogen receptor involved in oncogenesis.Low Molecular Weight Antagonists of Plasminogen Activator Inhibitor-1: Therapeutic Potential in Cardiovascular DiseaseInterventions for the prevention of dry socket: an evidence-based update.The inflammatory actions of coagulant and fibrinolytic proteases in disease.Vein graft failure: from pathophysiology to clinical outcomes.Urokinase-type plasminogen activator deficiency in bone marrow-derived cells augments rupture of angiotensin II-induced abdominal aortic aneurysms.The effect of regular colchicine treatment on biomarkers related with vascular injury in newly diagnosed patients with familial Mediterranean fever.Plasminogen-stimulated airway smooth muscle cell proliferation is mediated by urokinase and annexin A2, involving plasmin-activated cell signalling.The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.Reprogrammed streptokinases develop fibrin-targeting and dissolve blood clots with more potency than tissue plasminogen activator.Plasminogen activator inhibitor type 1 interacts with alpha3 subunit of proteasome and modulates its activity.Multifaceted role of plasminogen activator inhibitor-1 in regulating early remodeling of vein bypass grafts.Resolving distinct molecular origins for copper effects on PAI-1.Plasminogen activator inhibitor-1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen matrices.Statins as a novel therapeutic strategy in acute lung injury.High-resolution mass spectrometry proteomics for the identification of candidate plasma protein biomarkers for chronic obstructive pulmonary disease.GLUT10 Maintains the Integrity of Major Arteries through Regulation of Redox Homeostasis and Mitochondrial Function.Hypochlorous acid is a potent inactivator of human plasminogen at concentrations secreted by activated granulocytes.Inflammation in Vein Graft Disease.Plasminogen-stimulated inflammatory cytokine production by airway smooth muscle cells is regulated by annexin A2.Evaluation of various endothelial biomarkers in ankylosing spondylitis.Proteolytic degradation of neuropeptide Y (NPY) from head to toe: Identification of novel NPY-cleaving peptidases and potential drug interactions in CNS and Periphery.
P2860
Q28394962-064C04F5-FA3B-41D3-A638-D1FFABA1715FQ30399403-0A26227A-7699-400D-BC11-36730756DDE1Q30541611-2E7FFCC3-A79B-4977-B376-265DF389B1B7Q33393958-8BF8B650-BE83-418D-94EB-B8658B1270C4Q33889897-BE79925C-89A1-499E-BF38-3CFFED14A6EDQ33960827-8605E94A-4ECF-482B-8482-B5343CF74B9DQ34217461-3D68C173-A7E3-4909-926F-1388C6ED05ECQ34606581-93021274-191B-42C1-8AF3-8B6E7C78BB9BQ35661311-6185BCE0-A366-4A0E-B435-DBE281C58075Q35764595-20C79D75-5B32-4F49-A689-105347C78560Q35939755-7B8DC703-B807-493F-A76F-10412A794636Q36964350-95014ED2-7CB4-4B17-9E0A-716905E99DDCQ37017506-5C41AA32-F439-4A54-88B0-91E8EFB51BC9Q37292583-0A95F8BC-16E4-4D76-9261-3EE13FAA6CC5Q37400614-8010C87A-D994-44EC-A8C9-4960A19DD0A3Q37580170-8D14C82B-14D9-4F35-B775-B60F35ED82C2Q37627304-79D8A45B-6BA7-459D-B569-0828B243860EQ37967032-EBCD5A8B-DA97-4A53-8EB2-E84E2A4849C0Q38057218-1468077A-7DBE-41A9-BE0E-0CEF16082789Q38128321-AED5121F-3703-4E78-A5A7-57AF5333936AQ38228169-6F928659-5A9F-40EB-86BF-B40AF8D20087Q38423064-827DED81-36F7-4806-A993-3032CDC179BDQ38837879-4A4C203F-4B8E-4917-8335-D36111D2B85BQ39250854-AB65BBD1-8007-4B5D-B9D8-98EF9412AB08Q40298767-FAC46947-4CC8-480C-8392-6EA4A718B0F3Q41832184-97704ABA-6877-4942-8789-351C01832575Q41892701-52FCFACD-D647-4915-B836-EEF437E782ACQ41909356-D40ADB8F-330E-4BFA-873B-62A1DAFF383EQ42109406-9DA8816E-84EA-4471-82A3-872297A5CD6BQ42128982-F8C223EA-5A7F-4AFD-A0EA-C181376BC176Q42363774-42F518FC-9980-4F27-B55A-20B0C61029C6Q42425209-DD8782AA-B01E-486F-8DB2-7499CB5F79BBQ42991831-E1B27B41-ADE3-44DA-9C10-35F8124C8132Q44956259-7B0F5F33-E69D-41D3-9C95-874EE8D96440Q46259538-8F710A78-00D2-43F3-92E1-0D66B796017CQ46346231-6FF605BF-21DB-4CD7-B06B-331248396EC4Q50127096-1CE11F2B-53EB-44BE-9331-70D70AC89011Q50950460-095D4972-0A69-418F-BFA7-2E75DB371FD5Q51373483-FBECBBDB-9DD4-490E-8420-953D3C38AF63Q52148357-6E39D25F-FFD1-463F-8074-510E7D67E9BF
P2860
Vascular functions of the plasminogen activation system.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Vascular functions of the plasminogen activation system.
@ast
Vascular functions of the plasminogen activation system.
@en
type
label
Vascular functions of the plasminogen activation system.
@ast
Vascular functions of the plasminogen activation system.
@en
prefLabel
Vascular functions of the plasminogen activation system.
@ast
Vascular functions of the plasminogen activation system.
@en
P2093
P1476
Vascular functions of the plasminogen activation system.
@en
P2093
Madhavi Sunkar
Nadish Garg
William P Fay
P304
P356
10.1161/ATVBAHA.107.140046
P407
P577
2007-03-22T00:00:00Z